Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
AllAfrica on MSN6h
Nigeria: How Mohbad Died, Auxiliary Nurse Ogedengbe Reveals
Auxiliary nurse Feyisayo Ogedengbe, who administered a tetanus injection to late singer Ilerioluwa 'Mohbad' Aloba, has narrated how he died. On 6 October 2023, PREMIUM TIMES reported that the police ...
Alvotech S.A.: Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia and Xgeva
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...
Lawmakers consider restrictions to needle exchange programs
A bipartisan group of lawmakers representing Sanford is sponsoring the legislation, which went to a public hearing Monday. If ...